Clinical Trial Update: A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cisplatin or carboplatin plus etoposide with or without figitumumab in extensive-stage small cell lung cancer was terminated and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Figitumumab (figitumumab)

Snippet

Sponsor: Pfizer | Conditions: Small Cell Lung Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2013-02-25